ImmuCell Corporation Accumulated Other Comprehensive Income
ImmuCell Corporation (ICCC) had Accumulated Other Comprehensive Income of -$43.90 thousand as of 2019-12-31, per its 10-K filed 2021-03-30.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2021-03-30
- 2019-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$43.90K.
- 2019-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$65.23K.
- 2019-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$42.91K.
- 2019-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $3.09K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2019-12-31 | -$43.90K 10-K · filed 2021-03-30 |
| 2019-09-30 | -$65.23K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$42.91K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $3.09K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $30.16K 10-K · filed 2020-03-27 |
| 2018-09-30 | $73.79K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $59.46K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $43.22K 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$638.00 10-K · filed 2019-03-22 |
| 2017-09-30 | -$20.48K 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$22.31K 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$13.83K 10-Q · filed 2017-05-11 |
| 2016-12-31 | -$23.90K 10-K · filed 2018-03-29 |
| 2016-09-30 | -$130.02K 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$145.55K 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$115.33K 10-Q · filed 2016-05-11 |
| 2015-12-31 | -$50.26K 10-K · filed 2017-03-30 |
| 2015-09-30 | -$71.39K 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$22.24K 10-Q · filed 2015-08-13 |
| 2015-03-31 | -$27.24K 10-Q · filed 2015-05-12 |
| 2014-12-31 | -$23.33K 10-K · filed 2016-03-25 |
| 2014-09-30 | -$19.64K 10-Q · filed 2014-11-12 |
| 2014-06-30 | -$24.66K 10-Q · filed 2014-08-13 |
| 2014-03-31 | -$21.24K 10-Q · filed 2014-05-14 |
| 2013-12-31 | -$19.84K 10-K · filed 2015-03-26 |
| 2013-09-30 | -$25.84K 10-Q · filed 2013-11-13 |
| 2013-06-30 | -$25.89K 10-Q · filed 2013-08-13 |
| 2013-03-31 | -$44.31K 10-Q · filed 2013-05-14 |
| 2012-12-31 | -$50.12K 10-K · filed 2014-03-26 |
| 2012-09-30 | -$53.33K 10-Q · filed 2012-11-13 |
| 2012-06-30 | -$49.03K 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | -$35.20K 10-Q · filed 2012-05-14 |
| 2011-12-31 | -$40.81K 10-K · filed 2013-03-28 |
| 2011-09-30 | -$39.16K 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$2.31K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $9.63K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |